These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 28064520)

  • 1. Menopause, hormone therapy and diabetes.
    Stuenkel CA
    Climacteric; 2017 Feb; 20(1):11-21. PubMed ID: 28064520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update: estrogen and estrogen plus progestin therapy in the care of women at and after the menopause.
    Davey DA
    Womens Health (Lond); 2012 Mar; 8(2):169-89. PubMed ID: 22375720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does menopause increase diabetes risk? Strategies for diabetes prevention in midlife women.
    Kim C
    Womens Health (Lond); 2012 Mar; 8(2):155-67. PubMed ID: 22375719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopause and stroke and the effects of hormonal therapy.
    Lobo RA
    Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopause, Estrogens, and Glucose Homeostasis in Women.
    Mauvais-Jarvis F
    Adv Exp Med Biol; 2017; 1043():217-225. PubMed ID: 29224097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
    Speroff L
    Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormones and breast cancer: evidence and implications for consideration of risks and benefits of hormone replacement therapy.
    Colditz GA
    J Womens Health; 1999 Apr; 8(3):347-57. PubMed ID: 10326989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of diseases after menopause.
    Lobo RA; Davis SR; De Villiers TJ; Gompel A; Henderson VW; Hodis HN; Lumsden MA; Mack WJ; Shapiro S; Baber RJ
    Climacteric; 2014 Oct; 17(5):540-56. PubMed ID: 24969415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormones and cardiovascular health in women.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2006; 12(5):483-97. PubMed ID: 16807276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and progestogen effect on venous thromboembolism in menopausal women.
    Archer DF; Oger E
    Climacteric; 2012 Jun; 15(3):235-40. PubMed ID: 22612609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical evaluation of progestogens used in Menopausal Hormone Therapy (MHT)].
    Mueck AO
    Ther Umsch; 2021; 78(8):447-455. PubMed ID: 34555976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular health and the menopausal woman: the role of estrogen and when to begin and end hormone treatment.
    Naftolin F; Friedenthal J; Nachtigall R; Nachtigall L
    F1000Res; 2019; 8():. PubMed ID: 31543950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
    Rozenberg S; Al-Daghri N; Aubertin-Leheudre M; Brandi ML; Cano A; Collins P; Cooper C; Genazzani AR; Hillard T; Kanis JA; Kaufman JM; Lambrinoudaki I; Laslop A; McCloskey E; Palacios S; Prieto-Alhambra D; Reginster JY; Rizzoli R; Rosano G; Trémollieres F; Harvey NC
    Osteoporos Int; 2020 Dec; 31(12):2271-2286. PubMed ID: 32642851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Menopausal hormone therapy and the risk of type 2 diabetes mellitus: Health Insurance Database in South Korea-based retrospective cohort study.
    Yuk JS; Kim JM
    Menopause; 2023 May; 30(5):497-505. PubMed ID: 36917757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone therapy and breast cancer: the press-release version of WHI study data.
    Pines A
    Climacteric; 2013 Apr; 16(2):222-5. PubMed ID: 23488525
    [No Abstract]   [Full Text] [Related]  

  • 20. A review of menopausal hormone therapy: recalibrating the balance of benefit and risk.
    Rajan S; Kreatsoulas C
    Pol Arch Intern Med; 2019 Apr; 129(4):276-280. PubMed ID: 30608056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.